Stephane Oudard

20PUBLICATIONS
173CO-AUTHORS
Tumour immunologyPredictive and prognostic markersMolecular targetsLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 19, 2025
The CD70-CD27 Axis in Cancer Immunotherapy: Predictive Biomarker and Therapeutic Target.

Ikuan Sam, Nadine Ben Hamouda, Marina Alkatrib

|Oct 30, 2024
Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma.

Aude Fléchon, Rafael Morales-Barrera, Thomas Powles

|Mar 21, 2024
A Signal-Finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration-Resistant Prostate Cancer: Results from CYCLONE 1.

Neeraj Agarwal, Daniel Castellano, Teresa Alonso-Gordoa

|Feb 23, 2024
Belzutifan for von Hippel-Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study.

Tobias Else, Eric Jonasch, Othon Iliopoulos

|Jun 19, 2023
Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma.

Guillaume Davidson, Alexandra Helleux, Yann A Vano

|Dec 23, 2022
Renal Carcinoma and Angiogenesis: Therapeutic Target and Biomarkers of Response in Current Therapies.

Zoé Guillaume, Marie Auvray, Yann Vano

Pageof 4

Frequent Collaborators

5 joint publications

Yann-Alexandre Vano

4 joint publications

Catherine Sautès-Fridman

3 joint publications

Eric Tartour

3 joint publications

Virginie Verkarre